These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14199221)

  • 41. Recurrent viral infection (reinfection).
    Chang TW
    N Engl J Med; 1971 Apr; 284(14):765-73. PubMed ID: 4323312
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA; Novelli VM; Lipton SV; Pollock B
    Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
    Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacteriostasis and virology of herpetic lesions of the face and oral mucous membranes.
    Levin HL
    Oral Surg Oral Med Oral Pathol; 1965 Dec; 20(6):726-42. PubMed ID: 5215963
    [No Abstract]   [Full Text] [Related]  

  • 46. [Does vaccination for chickenpox prevent herpes zoster? (interview by Waldtraut Paukstadt)].
    Doerr HW
    MMW Fortschr Med; 2002 Dec; 144(50):12. PubMed ID: 14610859
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [CLINICAL OBSERVATIONS OF THE COEXISTENCE OF INFECTIONS].
    DE SALLES-GOMES LF; ALEVES-MEIRA J; DE OLIVEIRA BASTOS C; MACHADO CG; ANGULO JJ
    Med Monde; 1963; 39():53-5. PubMed ID: 14159545
    [No Abstract]   [Full Text] [Related]  

  • 49. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VIRUS INFECTIONS OF THE SKIN.
    CHURCH R
    Practitioner; 1964 May; 192():629-38. PubMed ID: 14147249
    [No Abstract]   [Full Text] [Related]  

  • 52. Viral infections in pregnancy.
    Horstmann DM
    Yale J Biol Med; 1969 Oct; 42(2):99-112. PubMed ID: 4317516
    [No Abstract]   [Full Text] [Related]  

  • 53. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccines for viral diseases with dermatologic manifestations.
    Brentjens MH; Yeung-Yue KA; Lee PC; Tyring SK
    Dermatol Clin; 2003 Apr; 21(2):349-69. PubMed ID: 12757257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [THE CURRENT STATUS OF OUR KNOWLEDGE OF THE VIRAL ETIOLOGY OF MALFORMATIONS, WITH SPECIAL REFERENCE TO CONGENITAL CARDIOPATHIES].
    BIANCONE S
    Ann Sanita Pubblica; 1964; 25():439-516. PubMed ID: 14183070
    [No Abstract]   [Full Text] [Related]  

  • 57. Viral infections of the skin. Herpes simplex, herpes zoster, warts, and molluscum contagiosum.
    Jarratt M
    Pediatr Clin North Am; 1978 May; 25(2):339-55. PubMed ID: 353674
    [No Abstract]   [Full Text] [Related]  

  • 58. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster.
    Littlewood KJ; Ouwens MJ; Sauboin C; Tehard B; Alain S; Denis F
    Clin Ther; 2015 Apr; 37(4):830-841.e7. PubMed ID: 25721380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seroprevalence of measles, mumps, rubella, and varicella amongphysicians and nurses in Jordan.
    Bakri FG; Abdelrahim ZM; Alkalbani AS; Khrais GM; Shamroukh DS; Hayajneh FA; Mahafza A
    Turk J Med Sci; 2016 Apr; 46(3):614-9. PubMed ID: 27513228
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic control of viral infections: chemotherapy, interferon and gamma globulin.
    St Geme JW
    Curr Probl Pediatr; 1979 Nov; 10(1):1-46. PubMed ID: 94280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.